JNK-ATF-2 inhibits thrombomodulin (TM) expression by recruiting histone deacetylase4 (HDAC4) and forming a transcriptional repression complex in the TM promoter

FEBS Letters
Yuanyuan RongYing H Shen

Abstract

Thrombomodulin (TM) is an important vascular protective molecule that has anticoagulant, anti-inflammatory and anti-apoptotic properties. TM is downregulated in many thrombotic and vascular diseases. However, the mechanisms responsible for TM suppression are not completely understood. In this study, we investigated the mechanism involved in fatty acid-induced suppression of TM expression in human aortic endothelial cells. We found that palmitic acid inhibited TM expression through the JNK and p38 pathways. ATF-2, a JNK and p38 target transcription factor, was involved in the suppression. ATF-2 can bind to the TM promoter, recruit HDAC4 and form a transcriptional repression complex in the promoter, which may lead to chromatin condensation and transcriptional arrest. This study provides novel insight into TM down-regulation by stress signaling pathways.

References

Feb 11, 1998·Experimental Cell Research·D S Calnek, B W Grinnell
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·S C HockingsD M Crothers
Jul 19, 2000·Circulation·J M WaughS L Woo
Jul 11, 2001·Critical Care Medicine·B Vallet, E Wiel
Sep 15, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·H WeilerJ I Weitz
May 11, 2002·Critical Care Medicine·Marcel LeviTom van der Poll
Jan 11, 2003·Circulation Research·Jason L SperryJeffrey J Rade
Jan 30, 2003·Annals of Medicine·Charles T Esmon
Apr 26, 2003·Blood·Daniel H SturnChristian J Wiedermann
Jul 17, 2003·Current Opinion in Lipidology·Kenneth K Wu
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·H Weiler, B H Isermann
May 1, 2004·Critical Care Medicine·Marlies Van de Wouwer, Edward M Conway
Oct 19, 2005·Cellular and Molecular Life Sciences : CMLS·G SumaraR Ricci
Apr 28, 2006·Current Atherosclerosis Reports·Neeta AdhikariJennifer L Hall
May 5, 2006·Seminars in Thrombosis and Hemostasis·Charles T Esmon
Mar 7, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·James P LuyendykNigel Mackman

❮ Previous
Next ❯

Citations

Aug 2, 2011·Seminars in Immunopathology·Edward M Conway
Oct 21, 2016·Thrombosis and Haemostasis·Alexander BreitensteinGiovanni G Camici
Apr 18, 2019·International Journal of Molecular Sciences·Hemant GiriAlireza R Rezaie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2021 Meta ULC. All rights reserved